Hsp70 inducers/coinducers are generally convincing for ALS treatment (Kalmar et al., 2014; Kalmar and Greensmith, 2017), and it is especially true for arimoclomol (Phukan, 2010). This evidence concerns the gene HSPA4 and amyotrophic lateral sclerosis.